EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19

Ignacio Sánchez-Moguel iD, Carmina Montiel, Ismael Bustos-Jaimes iD

Pathogens · 2023-08-02 · 12 (8) · 1007

DOI: 10.3390/pathogens12081007 ↗

At a glance

Übersichtsarbeit in Pathogens, published online on 2023-08-02. Written by Ignacio Sánchez-Moguel and 2 co-authors. Institution: Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico. Cited 4 times so far (Crossref); 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM, DGAPA-UNAM postdoctoral fellowship.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Virus-like particles (VLPs) comprise one or many structural components of virions, except their genetic material. Thus, VLPs keep their structural properties of cellular recognition while being non-infectious. VLPs of Parvovirus B19 (B19V) can be produced by the heterologous expression of their structural proteins VP1 and VP2 in bacteria. These proteins are purified under denaturing conditions, refolded, and assembled into VLPs. Moreover, chimeric forms of VP2 have been constructed to harbor peptides or functional proteins on the surface of the particles without dropping their competence to form VLPs, serving as presenting nanoparticles. The in-vitro assembly approach offers exciting possibilities for the composition of VLPs, as more than one chimeric form of VP2 can be included in the assembly stage, producing multifunctional VLPs. Here, the heterologous expression and in-vitro assembly of B19V structural proteins and their chimeras are reviewed. Considerations for the engineering of the structural proteins of B19V are also discussed. Finally, the construction of multifunctional VLPs and their future potential as innovative medical tools are examined.

Subjects

Author keywords

enzyme nanocarriersnanobiotecnologynanomedicineparvovirus-like particlesprotein engineering

Authors and institutions

  • Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
  • Departamento de Alimentos y Biotecnología, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.

ORCID profiles: Ignacio Sánchez-Moguel, Ismael Bustos-Jaimes

Funding

  • Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM
  • DGAPA-UNAM postdoctoral fellowship

Cite

APA

Sánchez-Moguel, I., Montiel, C., & Bustos-Jaimes, I. (2023). Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19. Pathogens, 12(8), 1007. https://doi.org/10.3390/pathogens12081007

Vancouver

Sánchez-Moguel I, Montiel C, Bustos-Jaimes I. Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19. Pathogens. 2023;12(8):1007. doi:10.3390/pathogens12081007

BibTeX
@article{SnchezMoguel2023,
  author = {Sánchez-Moguel, Ignacio and Montiel, Carmina and Bustos-Jaimes, Ismael},
  title = {Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {8},
  pages = {1007},
  doi = {10.3390/pathogens12081007}
}
Start for free →